KIMBERLY KESER: Open Payments
NPI 1053391151 · HARRISBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 34 payments from 15 companies in 2025. Trend: 2023 $1,353 · 2024 $1,032 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $229 |
| Novo Nordisk Inc | 5 | $196 |
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $140 |
| Madrigal Pharmaceuticals | 1 | $138 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Lilly USA, LLC | 4 | $67 |
| Medtronic, Inc. | 1 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Verona Pharma, Inc. | 2 | $37 |
Products named: JOURNAVX, REZDIFFRA, DEXCOM G7 GSS (161), Wegovy, AIRSUPRA, COBENFY, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across IL — which companies pay providers there.
